165 related articles for article (PubMed ID: 6119779)
21. Antisecretory agents, peptic secretion and serum pepsinogen in man.
Dobrilla G; Amplatz S; Benvenuti S; Comberlato M; Martini G
Ital J Gastroenterol; 1991 Feb; 23(2):100-6. PubMed ID: 1684121
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
Kett K; Aadland E; Berstad A
Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
[TBL] [Abstract][Full Text] [Related]
23. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
Gabryelewicz A; Sarosiek J; Laszewicz W
Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
[No Abstract] [Full Text] [Related]
24. Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans.
Maczka M; Kwiecień N; Obtułowicz W; Konturek SJ; Kamiński K; Oleksy J; Gabryelewicz A; Torres J
J Physiol Pharmacol; 1992 Jun; 43(2):139-48. PubMed ID: 1356519
[TBL] [Abstract][Full Text] [Related]
25. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
Sewing KF; Billian A; Malchow H
Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
[TBL] [Abstract][Full Text] [Related]
26. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
27. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
28. Effect of ranitidine (inhibitor of H2 receptors) after i.v. injection to patients treated in an intensive care unit: control of gastric acid secretion and estimation of drug plasma levels.
Macchi H; Fiasse R; Reynaert M; Desager JP; Dive C
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):306-7. PubMed ID: 6125133
[No Abstract] [Full Text] [Related]
29. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
Okabe S; Kawakami M
Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
[TBL] [Abstract][Full Text] [Related]
30. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
Miwa M; Tani N; Miwa T
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
[TBL] [Abstract][Full Text] [Related]
32. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
[TBL] [Abstract][Full Text] [Related]
33. Effects of misoprostol on histamine-related gastric secretion in man.
Wilson DE; Wilson PC
J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
[TBL] [Abstract][Full Text] [Related]
34. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
[TBL] [Abstract][Full Text] [Related]
35. Secretion of total pepsin and pepsin 1 in healthy volunteers in response to pentagastrin and to insulin-induced hypoglycaemia.
Roberts NB; Sheers R; Taylor WH
Scand J Gastroenterol; 2007 May; 42(5):555-61. PubMed ID: 17454875
[TBL] [Abstract][Full Text] [Related]
36. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion.
Mohammed R; Clark JS; Adams JF; Hearns JB; Crean GP
Clin Ther; 1981; 4(2):118-20. PubMed ID: 6117373
[TBL] [Abstract][Full Text] [Related]
37. Effects of four H2 histamine antagonists on bethanechol-stimulated acid and pepsin secretion in the dog.
Hirschowitz BI; Molina E
J Pharmacol Exp Ther; 1983 Feb; 224(2):341-5. PubMed ID: 6130143
[TBL] [Abstract][Full Text] [Related]
38. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
[TBL] [Abstract][Full Text] [Related]
39. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
Skrodzka D; Gabryelewicz A
Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
[TBL] [Abstract][Full Text] [Related]
40. Influence of intravenous pirenzepine on gastric acid and pepsin in man.
el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH
Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
